Genitourinary Cancer Clinical Trials

Clinical Trial: Atkins Diet and Prostate Cancer Clinical Trial

Clinical Trial: Patient Empowerment and Risk-assessed Treatment to Improve Outcome in the Elderly After Onco-surgery.

Clinical Trial: Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer

Clinical Trial: Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers

Clinical Trial: Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT)

Clinical Trial: Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium

Clinical Trial: Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions

Clinical Trial: Sunitinib Malate in Refractory Germ Cell Tumors

Clinical Trial: Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies

Clinical Trial: Study Comparing Bevacizumab + Temsirolimus Vs Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects (INTORACT)

Clinical Trials: A Phase III Blinded Study of Immediate Post-Turbt Instillation of Gemcitabine Versus Saline in Patients With Newly Diagnosed or Occasionally Recurring Grade I/II Superficial Bladder Cancer

Clinical Trials: Pilot Study of External Hyperthermia and Intravesical Mitomycin-C To Treat Recurrent Bladder Cancer After Resection and Standard Adjuvant Therapy

Clinical Trials: Molecular Analysis Of Bladder Cancer

Clinical Trials: Evaluation of Non-Invasive Assay(s) for the Detection of Bladder Cancer

Clinical Trial: Study Comparing Bevacizumab + Temsirolimus Vs Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects

For a complete listing of clinical trials pertaining to Genitourinary Cancer via ClinicalTrials.gov, click here.

Genitourinary Cancer News

Inherited high-risk mutation for prostate cancer identified

Music-playing headphones keep men calm during prostate biopsy

Experts have conflicting views on CV risk in prostate cancer therapy

Denosumab shown to delay bone metastases in prostate cancer

Costly clots common in cancer

Free CE from mycme.com

Discussions on Emerging Concepts and Controversies in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer

2.00 / AMA PRA Category 1 Credit(s)TM
This program reviews developments in maintenance therapy and evaluates the relevance of tumor histology and biomarker analysis for the management of NSCLC patients.
 

ONA Newsletters
Sign up today for one of our free newsletters:
  • Issue Preview
  • Latest CE
  • Reflections
  • Editor's choice
  • New on the Web
FEBRUARY 3 - 4
• 2012 Highlights of ASH in North America
New York, New York
• 2012 Highlights of ASH in North America
San Francisco, California
MARCH 3 - 4
• 2012 Highlights of ASH in Asia
Singapore, Singapore
MAY 3 - 6
• 37th Annual ONS Congress
New Orleans, Louisiana
Visit Reflections for first-hand stories on the power of the patient to impact caregivers in oncology nursing.

Web Exclusives

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions